243 related articles for article (PubMed ID: 26835368)
1. Somatic DNA mutation analysis in targeted therapy of solid tumours.
Yu B; O'Toole SA; Trent RJ
Transl Pediatr; 2015 Apr; 4(2):125-38. PubMed ID: 26835368
[TBL] [Abstract][Full Text] [Related]
2. [Molecular-Genetic Diagnosis and Molecular-Targeted Therapy in Cancer: Challenges in the Era of Precision Medicine].
Miyachi H
Rinsho Byori; 2015 Oct; 63(10):1188-93. PubMed ID: 26897855
[TBL] [Abstract][Full Text] [Related]
3. Next generation sequencing in cancer: opportunities and challenges for precision cancer medicine.
Paolillo C; Londin E; Fortina P
Scand J Clin Lab Invest Suppl; 2016; 245():S84-91. PubMed ID: 27542004
[TBL] [Abstract][Full Text] [Related]
4. [Lung cancer molecular testing, what role for Next Generation Sequencing and circulating tumor DNA].
Pécuchet N; Legras A; Laurent-Puig P; Blons H
Ann Pathol; 2016 Jan; 36(1):80-93. PubMed ID: 26803564
[TBL] [Abstract][Full Text] [Related]
5. Individualized network-based drug repositioning infrastructure for precision oncology in the panomics era.
Cheng F; Hong H; Yang S; Wei Y
Brief Bioinform; 2017 Jul; 18(4):682-697. PubMed ID: 27296652
[TBL] [Abstract][Full Text] [Related]
6. Genomic aberrations in spitzoid melanocytic tumours and their implications for diagnosis, prognosis and therapy.
Wiesner T; Kutzner H; Cerroni L; Mihm MC; Busam KJ; Murali R
Pathology; 2016 Feb; 48(2):113-31. PubMed ID: 27020384
[TBL] [Abstract][Full Text] [Related]
7. Advances in computational approaches for prioritizing driver mutations and significantly mutated genes in cancer genomes.
Cheng F; Zhao J; Zhao Z
Brief Bioinform; 2016 Jul; 17(4):642-56. PubMed ID: 26307061
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive next-generation cancer genome sequencing in the era of targeted therapy and personalized oncology.
Cronin M; Ross JS
Biomark Med; 2011 Jun; 5(3):293-305. PubMed ID: 21657839
[TBL] [Abstract][Full Text] [Related]
9. Translating cancer genomes sequencing revolution into surgical oncology practice.
Katsios C; Ziogas DE; Liakakos T; Zoras O; Roukos DH
J Surg Res; 2012 Apr; 173(2):365-9. PubMed ID: 21195428
[TBL] [Abstract][Full Text] [Related]
10. Targeted pharmacotherapy after somatic cancer mutation screening.
Polasek TM; Ambler K; Scott HS; Sorich MJ; Kaub PA; Rowland A; Wiese MD; Kichenadasse G
F1000Res; 2016; 5():1551. PubMed ID: 28163892
[TBL] [Abstract][Full Text] [Related]
11. Biomarkers for personalized oncology: recent advances and future challenges.
Kalia M
Metabolism; 2015 Mar; 64(3 Suppl 1):S16-21. PubMed ID: 25468140
[TBL] [Abstract][Full Text] [Related]
12. The possibility of clinical sequencing in the management of cancer.
Kou T; Kanai M; Matsumoto S; Okuno Y; Muto M
Jpn J Clin Oncol; 2016 May; 46(5):399-406. PubMed ID: 26917600
[TBL] [Abstract][Full Text] [Related]
13. Novel clinico-genome network modeling for revolutionizing genotype-phenotype-based personalized cancer care.
Roukos DH
Expert Rev Mol Diagn; 2010 Jan; 10(1):33-48. PubMed ID: 20014921
[TBL] [Abstract][Full Text] [Related]
14. The clinical trial landscape in oncology and connectivity of somatic mutational profiles to targeted therapies.
Patterson SE; Liu R; Statz CM; Durkin D; Lakshminarayana A; Mockus SM
Hum Genomics; 2016 Jan; 10():4. PubMed ID: 26772741
[TBL] [Abstract][Full Text] [Related]
15. Precision Medicine in Myelodysplastic Syndromes and Leukemias: Lessons from Sequential Mutations.
Nazha A; Sekeres MA
Annu Rev Med; 2017 Jan; 68():127-137. PubMed ID: 27618752
[TBL] [Abstract][Full Text] [Related]
16. [Genome sequencing and personalized medicine: perspectives and limitations].
Le Gall JY; Debré P;
Bull Acad Natl Med; 2014 Jan; 198(1):101-17. PubMed ID: 26259290
[TBL] [Abstract][Full Text] [Related]
17. PRESM: personalized reference editor for somatic mutation discovery in cancer genomics.
Cao C; Mak L; Jin G; Gordon P; Ye K; Long Q
Bioinformatics; 2019 May; 35(9):1445-1452. PubMed ID: 30247633
[TBL] [Abstract][Full Text] [Related]
18. Next-Generation Sequencing and Result Interpretation in Clinical Oncology: Challenges of Personalized Cancer Therapy.
Khotskaya YB; Mills GB; Mills Shaw KR
Annu Rev Med; 2017 Jan; 68():113-125. PubMed ID: 27813876
[TBL] [Abstract][Full Text] [Related]
19. Reviewing the somatic genetics of melanoma: from current to future analytical approaches.
Dutton-Regester K; Hayward NK
Pigment Cell Melanoma Res; 2012 Mar; 25(2):144-54. PubMed ID: 22248438
[TBL] [Abstract][Full Text] [Related]
20. Whole-exome sequencing reveals recurrent somatic mutation networks in cancer.
Liu X; Wang J; Chen L
Cancer Lett; 2013 Nov; 340(2):270-6. PubMed ID: 23153794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
